RU96124097A - NERVE CELL DIFFERENTIATION ACTIVATOR - Google Patents

NERVE CELL DIFFERENTIATION ACTIVATOR

Info

Publication number
RU96124097A
RU96124097A RU96124097/14A RU96124097A RU96124097A RU 96124097 A RU96124097 A RU 96124097A RU 96124097/14 A RU96124097/14 A RU 96124097/14A RU 96124097 A RU96124097 A RU 96124097A RU 96124097 A RU96124097 A RU 96124097A
Authority
RU
Russia
Prior art keywords
carrier
well
salt
pharmaceutically acceptable
active ingredient
Prior art date
Application number
RU96124097/14A
Other languages
Russian (ru)
Inventor
Комагата Даисуке
Морино Томио
Original Assignee
Ниппон Каяку Кабусики Кайся
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ниппон Каяку Кабусики Кайся filed Critical Ниппон Каяку Кабусики Кайся
Publication of RU96124097A publication Critical patent/RU96124097A/en

Links

Claims (4)

1. Активатор дифференцировки нервных клеток, который включает физиологически активное вещество N К175203 или его фармакологически приемлемую соль в качестве активного ингредиента, а также фармацевтически приемлемый наполнитель (наполнители) или носитель (носители).1. An activator of differentiation of nerve cells, which includes the physiologically active substance N K175203 or its pharmacologically acceptable salt as an active ingredient, as well as a pharmaceutically acceptable excipient (s) or carrier (s). 2. Лекарственное средство для лечения деменции, которое включает вещество по п. 1 или его соль в качестве активного ингредиента, а также фармацевтически приемлемый наполнитель (наполнители) или носитель (носители). 2. A medicament for treating dementia, which comprises a substance according to claim 1 or a salt thereof as an active ingredient, as well as a pharmaceutically acceptable excipient (s) or carrier (s). 3. Лекарственное средство, защищающее нервные клетки, которое включает вещество по п.1 или его соль в качестве активного ингридиента, а также фармацевтически приемлемый наполнитель (наполнители) или носитель (носители). 3. A medication that protects nerve cells, which includes the substance according to claim 1 or its salt as an active ingredient, as well as a pharmaceutically acceptable excipient (s) or carrier (s). 4. Лекарственное средство для лечения периферической невропатии, которое включает вещество по п. 1 или его соль в качестве активного ингредиента, а также фармацевтически приемлемый наполнитель (наполнители) или носитель (носители). 4. A medicament for treating peripheral neuropathy, which comprises the substance of claim 1 or a salt thereof as an active ingredient, as well as a pharmaceutically acceptable excipient (s) or carrier (s).
RU96124097/14A 1994-05-23 1995-05-15 NERVE CELL DIFFERENTIATION ACTIVATOR RU96124097A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP06-130796 1994-05-23

Publications (1)

Publication Number Publication Date
RU96124097A true RU96124097A (en) 1999-01-20

Family

ID=

Similar Documents

Publication Publication Date Title
HUT47217A (en) Process for producing pharmaceutical compositions containing indol derivatives as active components
FR2635265B1 (en) INTRAVENOUS PHARMACEUTICAL COMPOSITION COMPRISING CYCLOSPORIN AS ACTIVE INGREDIENT AND PROCESS FOR THE PREPARATION THEREOF
CA2193337A1 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
CA2386690A1 (en) Pharmaceutical tramadol salts
UA41446C2 (en) Use of fumagilol or its derivatives for preparing drugs intended for treating intestinal infection and pharmaceutical composition
FI961809A (en) Novel (R) -5-carbamoyl-8-fluoro-3-N, N-disubstituted amino 3,4-dihydro-2H-1-benzopyrans
UY26372A1 (en) "IMIDAZO-3-IL-AMINAS BICÍCLICAS PROCEDURE FOR ITS PREPARATION AND DRUGS THAT CONTAIN THEM"
ES2013067A6 (en) Piperazine derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
RU93036959A (en) FREE SOLUBLE MEDICATION WITH SLOW-UP ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES, ASSIGNED FOR RECEPTION INSIDE, THE METHOD OF ITS MANUFACTURE
HU9303675D0 (en) Substituted 4-phenyl-pyridone and 4-phenyl-2-alkoxy-pyridine derivatives
IT1226727B (en) PRECURSOR DRUGS OF DOPAMIN.
HU9201540D0 (en) Method for producing new polypeptides and pharmaceutical preparatives of effect against hiv virus containing these compounds as active substance
HU9202044D0 (en) Method for producing 4-phenyl-piperidine-4-carbixamide derivatives and pharmaceutical preparatives containing these compounds as active agents
CA2350659A1 (en) Pharmaceutical composition for modified release insulin sensitiser
HUP9901303A2 (en) A pharmaceutical composition for the treatment of autoimmune diseases
DE59001121D1 (en) Antacidatabletten.
CA2027814A1 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
AP9901474A0 (en) Pharmaceutical composition for treating viral diseases.
RU96124097A (en) NERVE CELL DIFFERENTIATION ACTIVATOR
DE68901172D1 (en) (-) - 2-PYRAZOLINE COMPOUND, THEIR OPTICAL UNLOCKING AND THERAPEUTIC AGENT FOR THE TREATMENT OF CEREBRAL VEGETABLE DISEASES, CONTAINING THIS COMPOUND AS AN ACTIVE INGREDIENT.
RU94046312A (en) Use of biologically active ureido-derivatives for treatment lentivirus-induced disease, products containing ureido-derivatives
ATE80036T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING AN 8-CHLORO-BENZOTHIAZEPINE COMPOUND AND ITS USE.
HUT58068A (en) Process for producing new, pharmacologically active compounds and pharmaceutical composition comprising same as acvtive ingredient
BR9710629A (en) Pharmaceutical composition Process for its preparation Compound for use as a therapeutic agent and use and use of a compound
WO1994016705A3 (en) Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders